Noven Pharmaceuticals Inc 2022-06-01 Health serious FDA
Health · FDA · Recall #FDA-D-0889-2022
Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr)… Recall
Issued June 1, 2022 · Noven Pharmaceuticals Inc
In June 2022, Noven Pharmaceuticals Inc recalled the Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr)…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Defective Delivery System: customer complaints exceeded respective action limits.
What you should do
- 1 Stop using Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr)… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Noven Pharmaceuticals Inc to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Noven Pharmaceuticals Inc
- Category
- Health
- Recall date
- June 1, 2022
- Units affected
- Not reported
- Sold at
- Nationwide to the U.S. Market
- Recall number
- FDA-D-0889-2022
- Made in
- United States
- Issuing agency
- FDA
In context
- Noven Pharmaceuticals Inc has 3 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 870th Health recall we've logged in 2022.